chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hypotension, Klebsiella test positive, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Brought to ED on 8/3 from skilled nursing facility for altered mental status and Covid +. Had been admitted to Medical Center in July with septic shock, cholangitis requiring ERCP/biliary stenting and bacteremia. There was concern for Cholangiocarcinoma but unable to peform EUS and was to f/u OP. He was then sent to facility. On arrival to ED he was hypotensive. Labs- creatinine 1.4, alk phos 976, AST 224 and ALT 224. WBC s elveated at 26. Hemoglobin 8.7. Had  UTI with blood cultures positive for kebsiella. Underwent CT of thorax , abdomen and pelvis showing cholelithiasis with gallbadder distentions concerning for cholecystitis. Biliary stent appeared in good position with dilatation concerning for cholangitis. General surgery consulted. After discussion with wife she decided to transition to comfort care. Palliative care and hospice were consulted. Comfort measures were initiated .
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Septic shock, Urinary tract infection, White blood cell count increased
Clinical narrative: Brought to ED on 8/3 from skilled nursing facility for altered mental status and Covid +. Had been admitted to Medical Center in July with septic shock, cholangitis requiring ERCP/biliary stenting and bacteremia. There was concern for Cholangiocarcinoma but unable to peform EUS and was to f/u OP. He was then sent to facility. On arrival to ED he was hypotensive. Labs- creatinine 1.4, alk phos 976, AST 224 and ALT 224. WBC s elveated at 26. Hemoglobin 8.7. Had  UTI with blood cultures positive for kebsiella. Underwent CT of thorax , abdomen and pelvis showing cholelithiasis with gallbadder distentions concerning for cholecystitis. Biliary stent appeared in good position with dilatation concerning for cholangitis. General surgery consulted. After discussion with wife she decided to transition to comfort care. Palliative care and hospice were consulted. Comfort measures were initiated .
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Patient states that she developed reddness on her face. not itchy no trouble breathing.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated 3 doses
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration
Clinical narrative: Patient developed COVID after 4 covid vaccinations given.does not show the lot number for vaccination 4, but the other three are as follows: 11/1/21 Moderna 076C21A; 2/2/21    Moderna 041L20A; 1/15/21 Moderna 037D20A
Age: 88.0
Sex: M
Vaccine: TD
Symptoms: Myalgia, Pain in extremity, Pain in jaw
Clinical narrative: He got his tetanus vaccine, all of his muscle in his whole body hurt.  At nighttime his legs are really bad, he has to put a pillow under his knees, but it's all of his muscles including his jaw.  It hurts to close his mouth.  He called his doctor and he told him to take Excedrin, which does not do anything.  The symptoms have not improved any, it just stays the same.  If it was not his whole body he would not be concerned, but it is and he's concerned about it.  It's none of the symptoms that are typical of the vaccine.
Age: 19.0
Sex: F
Vaccine: MENB
Symptoms: Expired product administered
Clinical narrative: Patient was given an expired vaccination.  Expiration date of 07/31/2022.  Patient was notified at the time of visit, she was feeling fine when she was discharged from the visit today.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Patient was admitted to the hospital with COVID-19
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID infection. Symptom of shortness of breath. Onset of shortness of breath unknown. Positive test collected 08/01/2022
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ
Symptoms: Arthralgia
Clinical narrative: polyarthralgia
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid test in fully vaccinated pt
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Inappropriate dose for age given. No immediate or after affects reported.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid test in fully vaccinated pt
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine was given past the beyond use date.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Gait disturbance, Joint swelling, Magnetic resonance imaging normal
Clinical narrative: After first pfizer booster shot, 13 days later my shoulder and knee joints swelled up and I had extreme pain to the point I could barely walk. Had MRI on shoulders and nothing showed up that would cause this kind of pain and swelling. I have been put on prednisone 3 or 4 times now. it is the only thing that helps. I am now on 5 mg prednisone once a day and hydroxychloroquine 200 MG tablet twice a day
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Patient was admitted to the hospital with COVID-19
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was given after the beyond use date.  No reactions reported
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated (2 doses mRNA )
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given after the beyond use date. no reactions reported
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Allergy test, Blood test, Colonoscopy, Computerised tomogram abdomen, Endoscopy upper gastrointestinal tract
Clinical narrative: Approximately 1 month after second vaccine, I started exhibiting intestinal cramps in the transverse colon. Approx. 2 weeks after that, the pain traveled to the corners of my large intestine. Pain ranges from "knots" to stabbing slashing pain. Most of the time pain presents as a constant punching pain. Pain is present during physical activity, eating, and digesting. No specific food is responsible, it is volume of food (sometimes minimal amounts) that trigger pain. 75 -80% of the time, when food enters the stomach, pain presents in my ascending colon / transverse colon corner (rt side). Pain is mobile from there to other corners of large intestine. Pain "bounces" from one corner to another without pattern. No change in diet. No change in routine, it was Covid lock down time, minimal outside interaction with people. No new medicines, and routine same for months.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Gastric emptying study, Gastrointestinal pain, Stool analysis, Ultrasound abdomen
Clinical narrative: Approximately 1 month after second vaccine, I started exhibiting intestinal cramps in the transverse colon. Approx. 2 weeks after that, the pain traveled to the corners of my large intestine. Pain ranges from "knots" to stabbing slashing pain. Most of the time pain presents as a constant punching pain. Pain is present during physical activity, eating, and digesting. No specific food is responsible, it is volume of food (sometimes minimal amounts) that trigger pain. 75 -80% of the time, when food enters the stomach, pain presents in my ascending colon / transverse colon corner (rt side). Pain is mobile from there to other corners of large intestine. Pain "bounces" from one corner to another without pattern. No change in diet. No change in routine, it was Covid lock down time, minimal outside interaction with people. No new medicines, and routine same for months.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given past the beyond use date. No reactions reported
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given after the beyond use date. No reactions reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid test in fully vaccinated pt
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given past the beyond use date. No reactions reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given past the beyond use date. No reactions were reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given past the beyond use date. No reactions reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cardiac arrest, Death, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: pt became unresponsive/unconscious at home; family called EMS and started CPR; EMS arrived and took over CPR, ACLS protocol, intubated pt; family stated pt had been positive for COVID on 9/14/21 and had become more congested with dyspnea that day; EKG showed PEA then asystole; brought to ED with continued CPR; pt  expired in the ED (Medical Center)
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, Life support, Loss of consciousness, Pulseless electrical activity, Respiratory tract congestion
Clinical narrative: pt became unresponsive/unconscious at home; family called EMS and started CPR; EMS arrived and took over CPR, ACLS protocol, intubated pt; family stated pt had been positive for COVID on 9/14/21 and had become more congested with dyspnea that day; EKG showed PEA then asystole; brought to ED with continued CPR; pt  expired in the ED (Medical Center)
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Resuscitation, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: pt became unresponsive/unconscious at home; family called EMS and started CPR; EMS arrived and took over CPR, ACLS protocol, intubated pt; family stated pt had been positive for COVID on 9/14/21 and had become more congested with dyspnea that day; EKG showed PEA then asystole; brought to ED with continued CPR; pt  expired in the ED (Medical Center)
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Bloom consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the DPHE on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated (2 doses mRNA )
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was given past the Beyond use date
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine was given paste beyond use date. No reactions reported.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated 2 doses
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given past the Beyond use date. No reactions were reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local dept of health on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Diarrhoea, Disturbance in attention, Fatigue, Flushing, Headache
Clinical narrative: Severe headache and neckache. Nausea, vomiting,  diarrhea. Profound fatigue. Facial flushing. Injection site: red, hot indurated, 12 centimeters in diameter.  Inability to focus, poor concentration, lack of mental clarity,  and memory problems.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Injection site erythema, Injection site induration, Injection site warmth, Memory impairment, Nausea
Clinical narrative: Severe headache and neckache. Nausea, vomiting,  diarrhea. Profound fatigue. Facial flushing. Injection site: red, hot indurated, 12 centimeters in diameter.  Inability to focus, poor concentration, lack of mental clarity,  and memory problems.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Neck pain, Vomiting
Clinical narrative: Severe headache and neckache. Nausea, vomiting,  diarrhea. Profound fatigue. Facial flushing. Injection site: red, hot indurated, 12 centimeters in diameter.  Inability to focus, poor concentration, lack of mental clarity,  and memory problems.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine was given paste beyond use date. No reactions were reported.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local healthcare service is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 45.0
Sex: F
Vaccine: RAB
Symptoms: Blood pressure increased, Chest discomfort, Dizziness, Feeling hot, Hypersensitivity
Clinical narrative: I had an allergic reaction to my day 3 vaccine as well but not as severe. Day 7 booster, around 7 minutes after vaccine, my body became warm feeling, it felt as though I was breathing in warm air. My face & chest felt "full", as if I could feel the medicine pulsing through it. I felt like I was going to pass out. It was strong, intense & scary. My blood pressure on the day 3 shot went up to 160; 139 on thr day 7 shot. The next day, I felt the same way & could barely function until afternoon.
Age: 45.0
Sex: F
Vaccine: RAB
Symptoms: Sensory disturbance, Swelling face
Clinical narrative: I had an allergic reaction to my day 3 vaccine as well but not as severe. Day 7 booster, around 7 minutes after vaccine, my body became warm feeling, it felt as though I was breathing in warm air. My face & chest felt "full", as if I could feel the medicine pulsing through it. I felt like I was going to pass out. It was strong, intense & scary. My blood pressure on the day 3 shot went up to 160; 139 on thr day 7 shot. The next day, I felt the same way & could barely function until afternoon.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: 47 RESIDENTS RECEIVED A BOOSTER PFIZER SHOT PAST THE bud
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Medical office consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated with 3 doses Moderna.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Facility consulted with the Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Facility is working with the DPHE on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Computerised tomogram, Fatigue, Feeling cold, Headache
Clinical narrative: I WAS OK THAT DAY JUST A BIT TIRED ANS WENY TO WORK. I WOKE UP THE NEXT DAY WITH CHILLS AND I STARTED WITH A HEADACH AND THE SECOND DAY I WOKE UP WITH BACK PAIN AND ENT TO THE ER BUT WAS NOT ADMITTED. THEY GAVE ME A TORADOL INJECTION AND DID A URIN TEST. THEN SENT ME HOME WITH INSTRUCTIONS TO TAKE IBPROPHEN.   SEEN DR. ON JULY 26 FOR THE DAME THING AND SHE DID PROSCRIBE A MUSCLE RELAXER AND ONCE A DAY ANTI-INFLAMATORY MYLOXICAM.   METHOCARBAMOL 500 GM.   2ND ER ON 7/27/2022 TO ER FOR ANOTHER 8 HOURS THEY DID ANOTHER URINE TEST, XRAY OF BACK HIP AND CT WITH CONTRAST AND NOTHING FOUND. SENT HOME AFTER THAT.  ABOUT TO WEEKS TO THE DAY MY BACK STOPED HURTING. YESTERDAY I STARTED FILLING LIKE MY TONSILS WERE IN THE WAY SO I WENT TO THE URGENT CARE AT WALKIN. THEY SAID EVERYTHIN LOOKED GOOD WITH NO INFECTION BUT IT LOOKED LIKE MUCOUS AND POST NASIL DRIP.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Scan with contrast, Secretion discharge, Streptococcus test negative, Tonsillar disorder
Clinical narrative: I WAS OK THAT DAY JUST A BIT TIRED ANS WENY TO WORK. I WOKE UP THE NEXT DAY WITH CHILLS AND I STARTED WITH A HEADACH AND THE SECOND DAY I WOKE UP WITH BACK PAIN AND ENT TO THE ER BUT WAS NOT ADMITTED. THEY GAVE ME A TORADOL INJECTION AND DID A URIN TEST. THEN SENT ME HOME WITH INSTRUCTIONS TO TAKE IBPROPHEN.   SEEN DR. ON JULY 26 FOR THE DAME THING AND SHE DID PROSCRIBE A MUSCLE RELAXER AND ONCE A DAY ANTI-INFLAMATORY MYLOXICAM.   METHOCARBAMOL 500 GM.   2ND ER ON 7/27/2022 TO ER FOR ANOTHER 8 HOURS THEY DID ANOTHER URINE TEST, XRAY OF BACK HIP AND CT WITH CONTRAST AND NOTHING FOUND. SENT HOME AFTER THAT.  ABOUT TO WEEKS TO THE DAY MY BACK STOPED HURTING. YESTERDAY I STARTED FILLING LIKE MY TONSILS WERE IN THE WAY SO I WENT TO THE URGENT CARE AT WALKIN. THEY SAID EVERYTHIN LOOKED GOOD WITH NO INFECTION BUT IT LOOKED LIKE MUCOUS AND POST NASIL DRIP.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Upper-airway cough syndrome, Urine analysis, X-ray normal, X-ray of pelvis and hip normal
Clinical narrative: I WAS OK THAT DAY JUST A BIT TIRED ANS WENY TO WORK. I WOKE UP THE NEXT DAY WITH CHILLS AND I STARTED WITH A HEADACH AND THE SECOND DAY I WOKE UP WITH BACK PAIN AND ENT TO THE ER BUT WAS NOT ADMITTED. THEY GAVE ME A TORADOL INJECTION AND DID A URIN TEST. THEN SENT ME HOME WITH INSTRUCTIONS TO TAKE IBPROPHEN.   SEEN DR. ON JULY 26 FOR THE DAME THING AND SHE DID PROSCRIBE A MUSCLE RELAXER AND ONCE A DAY ANTI-INFLAMATORY MYLOXICAM.   METHOCARBAMOL 500 GM.   2ND ER ON 7/27/2022 TO ER FOR ANOTHER 8 HOURS THEY DID ANOTHER URINE TEST, XRAY OF BACK HIP AND CT WITH CONTRAST AND NOTHING FOUND. SENT HOME AFTER THAT.  ABOUT TO WEEKS TO THE DAY MY BACK STOPED HURTING. YESTERDAY I STARTED FILLING LIKE MY TONSILS WERE IN THE WAY SO I WENT TO THE URGENT CARE AT WALKIN. THEY SAID EVERYTHIN LOOKED GOOD WITH NO INFECTION BUT IT LOOKED LIKE MUCOUS AND POST NASIL DRIP.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, Blood lactic acid, COVID-19
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer BIO-NTech vaccine on 2/13/21, 3/06/21 and 12/03/21. Presented to ED 7/30 c/o fatigue x3days. In ED, fever of 100.4, spO2 91% on R and RR 26 and hypotensive. Admitted for Covid PNA w/acute resp failure and AKI. Cr was 1.41, lactic 0.7. Required High Flow oxygen as well as bipap to maintain oxygenation. He had an acute decline overnight on 8/3 and was transitioned to DNR/DNI. Expired on 8/3/22. Treated w/azithromycin, ceftriaxone, vancyomycin, aztreonam, levofloxacin, remdesivir, tocilizumab, and decadron.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Death, Fatigue, General physical health deterioration, Hypotension
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer BIO-NTech vaccine on 2/13/21, 3/06/21 and 12/03/21. Presented to ED 7/30 c/o fatigue x3days. In ED, fever of 100.4, spO2 91% on R and RR 26 and hypotensive. Admitted for Covid PNA w/acute resp failure and AKI. Cr was 1.41, lactic 0.7. Required High Flow oxygen as well as bipap to maintain oxygenation. He had an acute decline overnight on 8/3 and was transitioned to DNR/DNI. Expired on 8/3/22. Treated w/azithromycin, ceftriaxone, vancyomycin, aztreonam, levofloxacin, remdesivir, tocilizumab, and decadron.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer BIO-NTech vaccine on 2/13/21, 3/06/21 and 12/03/21. Presented to ED 7/30 c/o fatigue x3days. In ED, fever of 100.4, spO2 91% on R and RR 26 and hypotensive. Admitted for Covid PNA w/acute resp failure and AKI. Cr was 1.41, lactic 0.7. Required High Flow oxygen as well as bipap to maintain oxygenation. He had an acute decline overnight on 8/3 and was transitioned to DNR/DNI. Expired on 8/3/22. Treated w/azithromycin, ceftriaxone, vancyomycin, aztreonam, levofloxacin, remdesivir, tocilizumab, and decadron.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough case of COVID-19 after fully vaccinated and boosted with mRNA vaccine.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardiomegaly, Chest X-ray abnormal, Chest discomfort
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA. Rec'd Pfizer-BioNTech COVID-19 Vaccine on 1/22/2021 and 3/3/2021. Presented to ER on 7/15 w/low grade fever, chills, runny nose, sore throat, chest tightness, and SOB, Covid+. Admitted for Covid PNA. CXR w/Cardiomegaly and improving patchy bilateral pleural effusions. CT of the chest Volume overload. Transferred to ICU for worsening hypoxia. Continuous BiPAP support, but no improvement and remained hypoxemic and encephalopathic. Transitioned to DNR. Expired 8/4/2022. Pt received cefepime, vancomycin, metronidazole, dexamethasone.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Computerised tomogram thorax abnormal, Death, Dyspnoea, Encephalopathy
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA. Rec'd Pfizer-BioNTech COVID-19 Vaccine on 1/22/2021 and 3/3/2021. Presented to ER on 7/15 w/low grade fever, chills, runny nose, sore throat, chest tightness, and SOB, Covid+. Admitted for Covid PNA. CXR w/Cardiomegaly and improving patchy bilateral pleural effusions. CT of the chest Volume overload. Transferred to ICU for worsening hypoxia. Continuous BiPAP support, but no improvement and remained hypoxemic and encephalopathic. Transitioned to DNR. Expired 8/4/2022. Pt received cefepime, vancomycin, metronidazole, dexamethasone.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypervolaemia, Hypoxia, Inappropriate schedule of product administration, Intensive care, Oropharyngeal pain
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA. Rec'd Pfizer-BioNTech COVID-19 Vaccine on 1/22/2021 and 3/3/2021. Presented to ER on 7/15 w/low grade fever, chills, runny nose, sore throat, chest tightness, and SOB, Covid+. Admitted for Covid PNA. CXR w/Cardiomegaly and improving patchy bilateral pleural effusions. CT of the chest Volume overload. Transferred to ICU for worsening hypoxia. Continuous BiPAP support, but no improvement and remained hypoxemic and encephalopathic. Transitioned to DNR. Expired 8/4/2022. Pt received cefepime, vancomycin, metronidazole, dexamethasone.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pleural effusion, Positive airway pressure therapy, Pyrexia, Rhinorrhoea, SARS-CoV-2 antibody test negative
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA. Rec'd Pfizer-BioNTech COVID-19 Vaccine on 1/22/2021 and 3/3/2021. Presented to ER on 7/15 w/low grade fever, chills, runny nose, sore throat, chest tightness, and SOB, Covid+. Admitted for Covid PNA. CXR w/Cardiomegaly and improving patchy bilateral pleural effusions. CT of the chest Volume overload. Transferred to ICU for worsening hypoxia. Continuous BiPAP support, but no improvement and remained hypoxemic and encephalopathic. Transitioned to DNR. Expired 8/4/2022. Pt received cefepime, vancomycin, metronidazole, dexamethasone.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA. Rec'd Pfizer-BioNTech COVID-19 Vaccine on 1/22/2021 and 3/3/2021. Presented to ER on 7/15 w/low grade fever, chills, runny nose, sore throat, chest tightness, and SOB, Covid+. Admitted for Covid PNA. CXR w/Cardiomegaly and improving patchy bilateral pleural effusions. CT of the chest Volume overload. Transferred to ICU for worsening hypoxia. Continuous BiPAP support, but no improvement and remained hypoxemic and encephalopathic. Transitioned to DNR. Expired 8/4/2022. Pt received cefepime, vancomycin, metronidazole, dexamethasone.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Bradycardia, COVID-19, Chest X-ray abnormal, Computerised tomogram head normal
Clinical narrative: 3/16/22 pt to ED via EMS; pt unresponsive; hypoxic with O2 saturation in 80s%; intubated; pt had a positive COVID test 1/23/22 per family and had been treated; pt became bradycardic and hypotensive; resuscitated; CT of head showed no acute abnormalities; CXR showed bilateral infiltrates; given IV ABX; Atrial Fibrillation treated with medication;  pt suffered another PEA arrest; ROSC achieved after 8 mins of CPR; pt then hypertensive and tachycardic; family decided no more CPR; pt expired in the hospital
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Endotracheal intubation, Hypertension, Hypotension, Hypoxia
Clinical narrative: 3/16/22 pt to ED via EMS; pt unresponsive; hypoxic with O2 saturation in 80s%; intubated; pt had a positive COVID test 1/23/22 per family and had been treated; pt became bradycardic and hypotensive; resuscitated; CT of head showed no acute abnormalities; CXR showed bilateral infiltrates; given IV ABX; Atrial Fibrillation treated with medication;  pt suffered another PEA arrest; ROSC achieved after 8 mins of CPR; pt then hypertensive and tachycardic; family decided no more CPR; pt expired in the hospital
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Pulseless electrical activity, Resuscitation, SARS-CoV-2 test positive, Tachycardia
Clinical narrative: 3/16/22 pt to ED via EMS; pt unresponsive; hypoxic with O2 saturation in 80s%; intubated; pt had a positive COVID test 1/23/22 per family and had been treated; pt became bradycardic and hypotensive; resuscitated; CT of head showed no acute abnormalities; CXR showed bilateral infiltrates; given IV ABX; Atrial Fibrillation treated with medication;  pt suffered another PEA arrest; ROSC achieved after 8 mins of CPR; pt then hypertensive and tachycardic; family decided no more CPR; pt expired in the hospital
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: 3/16/22 pt to ED via EMS; pt unresponsive; hypoxic with O2 saturation in 80s%; intubated; pt had a positive COVID test 1/23/22 per family and had been treated; pt became bradycardic and hypotensive; resuscitated; CT of head showed no acute abnormalities; CXR showed bilateral infiltrates; given IV ABX; Atrial Fibrillation treated with medication;  pt suffered another PEA arrest; ROSC achieved after 8 mins of CPR; pt then hypertensive and tachycardic; family decided no more CPR; pt expired in the hospital
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. HCF consulted with the local Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. The HCF is working with the local dept of health on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardio-respiratory arrest, Death, Delirium, Dementia
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Moderna vaccine on 1/28/21 and 2/25/21. Recently dx'd w/covid 19 w/delirium on dementia, encephalopathy, and completed paxlovid. Upon assessment pt was with shallow breaths, cold extremities, and weak thready pulse. Nonrebreather mask was placed on pt, and during further examination became unresponsive resulting in a code and CPR. Intubated and transferred to ICU where he expired within minutes. Pt expired on 8/3. Tx'd with azithromycin, vancomycin, and zosyn, ceftriaxone, and paxlovid.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Encephalopathy, Endotracheal intubation, Hypopnoea, Intensive care, Mental status changes
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Moderna vaccine on 1/28/21 and 2/25/21. Recently dx'd w/covid 19 w/delirium on dementia, encephalopathy, and completed paxlovid. Upon assessment pt was with shallow breaths, cold extremities, and weak thready pulse. Nonrebreather mask was placed on pt, and during further examination became unresponsive resulting in a code and CPR. Intubated and transferred to ICU where he expired within minutes. Pt expired on 8/3. Tx'd with azithromycin, vancomycin, and zosyn, ceftriaxone, and paxlovid.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral coldness, Pulse abnormal, Resuscitation, SARS-CoV-2 test, Unresponsive to stimuli
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Moderna vaccine on 1/28/21 and 2/25/21. Recently dx'd w/covid 19 w/delirium on dementia, encephalopathy, and completed paxlovid. Upon assessment pt was with shallow breaths, cold extremities, and weak thready pulse. Nonrebreather mask was placed on pt, and during further examination became unresponsive resulting in a code and CPR. Intubated and transferred to ICU where he expired within minutes. Pt expired on 8/3. Tx'd with azithromycin, vancomycin, and zosyn, ceftriaxone, and paxlovid.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Death, Endotracheal intubation, Gastrointestinal tube insertion
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA Rec'd Pfizer-BioNTech COVID-19 Vaccine on 2/4/2021 and 2/25/2021. Transferred arrived with worsening hypercalcemia and acute hypoxic resp fail requiring BiPAP. Intubated and NG tube placed. Failed weaning trials. Had an A-fib with RVR event and hypotension. Transitioned to DNR/COT on 7/28. Continued on full vent support and became febrile. Pt expired 8/4/2022. Tx'd w/cefepime, vancomycin, meropenem, metronidazole, and dexamethasone.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypercalcaemia, Hypotension, Mechanical ventilation, Positive airway pressure therapy, Pyrexia
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA Rec'd Pfizer-BioNTech COVID-19 Vaccine on 2/4/2021 and 2/25/2021. Transferred arrived with worsening hypercalcemia and acute hypoxic resp fail requiring BiPAP. Intubated and NG tube placed. Failed weaning trials. Had an A-fib with RVR event and hypotension. Transitioned to DNR/COT on 7/28. Continued on full vent support and became febrile. Pt expired 8/4/2022. Tx'd w/cefepime, vancomycin, meropenem, metronidazole, and dexamethasone.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA Rec'd Pfizer-BioNTech COVID-19 Vaccine on 2/4/2021 and 2/25/2021. Transferred arrived with worsening hypercalcemia and acute hypoxic resp fail requiring BiPAP. Intubated and NG tube placed. Failed weaning trials. Had an A-fib with RVR event and hypotension. Transitioned to DNR/COT on 7/28. Continued on full vent support and became febrile. Pt expired 8/4/2022. Tx'd w/cefepime, vancomycin, meropenem, metronidazole, and dexamethasone.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the local Dept. of Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Local Healthcare is working on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, Blood lactic acid normal, Blood pH increased, Blood potassium increased
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Pfizer BIO-NTech vaccine on 9/1/21 and 9/22/21. Recent admission 7/16/22 for acute hypoxemic resp fail 2/2 covid-19 c/b acute encephalopathy, severe COPD and CKD3. Tmax 101.7, RR mid 20s, satting mid to high 90s on 4L. CBC and CMP wnl, Cr 1.44. Lactate and Procal wnl. Trop/BNP wnl. CXR negative  D/c'd 7/20 and readmitted 7/20. EMS reported pt noted with SPO2 87% on room air, placed on 4L with resultant SPO2 100%. VS on arrival significant for RR 24, SPO2 91% on RA; BUN 32, Cr 1.44, K+ 5.3, PCO2 28, Ph 7.46, WBC 9.3, UA (-) for UTI; CXR with increased interstitial markings likely scarring at lung bases but no acute process. Transitioned to hospice. Expired 8/1/22. Tx'd w/decadron and cefepime over entire stay.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood urea increased, Body temperature increased, Brain natriuretic peptide normal, COVID-19, Chest X-ray abnormal
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Pfizer BIO-NTech vaccine on 9/1/21 and 9/22/21. Recent admission 7/16/22 for acute hypoxemic resp fail 2/2 covid-19 c/b acute encephalopathy, severe COPD and CKD3. Tmax 101.7, RR mid 20s, satting mid to high 90s on 4L. CBC and CMP wnl, Cr 1.44. Lactate and Procal wnl. Trop/BNP wnl. CXR negative  D/c'd 7/20 and readmitted 7/20. EMS reported pt noted with SPO2 87% on room air, placed on 4L with resultant SPO2 100%. VS on arrival significant for RR 24, SPO2 91% on RA; BUN 32, Cr 1.44, K+ 5.3, PCO2 28, Ph 7.46, WBC 9.3, UA (-) for UTI; CXR with increased interstitial markings likely scarring at lung bases but no acute process. Transitioned to hospice. Expired 8/1/22. Tx'd w/decadron and cefepime over entire stay.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chronic kidney disease, Chronic obstructive pulmonary disease, Condition aggravated, Death, Encephalopathy
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Pfizer BIO-NTech vaccine on 9/1/21 and 9/22/21. Recent admission 7/16/22 for acute hypoxemic resp fail 2/2 covid-19 c/b acute encephalopathy, severe COPD and CKD3. Tmax 101.7, RR mid 20s, satting mid to high 90s on 4L. CBC and CMP wnl, Cr 1.44. Lactate and Procal wnl. Trop/BNP wnl. CXR negative  D/c'd 7/20 and readmitted 7/20. EMS reported pt noted with SPO2 87% on room air, placed on 4L with resultant SPO2 100%. VS on arrival significant for RR 24, SPO2 91% on RA; BUN 32, Cr 1.44, K+ 5.3, PCO2 28, Ph 7.46, WBC 9.3, UA (-) for UTI; CXR with increased interstitial markings likely scarring at lung bases but no acute process. Transitioned to hospice. Expired 8/1/22. Tx'd w/decadron and cefepime over entire stay.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count normal, Metabolic function test normal, PCO2 decreased, Procalcitonin normal, Pulmonary fibrosis
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Pfizer BIO-NTech vaccine on 9/1/21 and 9/22/21. Recent admission 7/16/22 for acute hypoxemic resp fail 2/2 covid-19 c/b acute encephalopathy, severe COPD and CKD3. Tmax 101.7, RR mid 20s, satting mid to high 90s on 4L. CBC and CMP wnl, Cr 1.44. Lactate and Procal wnl. Trop/BNP wnl. CXR negative  D/c'd 7/20 and readmitted 7/20. EMS reported pt noted with SPO2 87% on room air, placed on 4L with resultant SPO2 100%. VS on arrival significant for RR 24, SPO2 91% on RA; BUN 32, Cr 1.44, K+ 5.3, PCO2 28, Ph 7.46, WBC 9.3, UA (-) for UTI; CXR with increased interstitial markings likely scarring at lung bases but no acute process. Transitioned to hospice. Expired 8/1/22. Tx'd w/decadron and cefepime over entire stay.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Troponin normal, Urine analysis normal, White blood cell count normal
Clinical narrative: Pfizer BIO-NTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Pfizer BIO-NTech vaccine on 9/1/21 and 9/22/21. Recent admission 7/16/22 for acute hypoxemic resp fail 2/2 covid-19 c/b acute encephalopathy, severe COPD and CKD3. Tmax 101.7, RR mid 20s, satting mid to high 90s on 4L. CBC and CMP wnl, Cr 1.44. Lactate and Procal wnl. Trop/BNP wnl. CXR negative  D/c'd 7/20 and readmitted 7/20. EMS reported pt noted with SPO2 87% on room air, placed on 4L with resultant SPO2 100%. VS on arrival significant for RR 24, SPO2 91% on RA; BUN 32, Cr 1.44, K+ 5.3, PCO2 28, Ph 7.46, WBC 9.3, UA (-) for UTI; CXR with increased interstitial markings likely scarring at lung bases but no acute process. Transitioned to hospice. Expired 8/1/22. Tx'd w/decadron and cefepime over entire stay.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Cardiac failure acute, Chronic kidney disease, Chronic obstructive pulmonary disease
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Moderna vaccine on 2/25/21, 3/24/21 and 11/26/21. Recent admit 7/24-26/22 for acute on chronic systolic HF, bacterial and crytogenic PNA, Covid (+ on 7/23), COPD exacerbation and CKD3.  Readmitted on 8/1 for acute on chronic respiratory failure with hypoxia and PNA. Subsequently decompensated - transferred to ICU, intubated and placed on pressors. Developed rapidly worsening refractory pressor dependent shock and multi-system organ failure. Transitioned to comfort care. Expired 8/5. Tx'd with meropenem, cefepime, methylprednisolone, and nystatin.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Endotracheal intubation, General physical health deterioration, Hypoxia, Inappropriate schedule of product administration
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Moderna vaccine on 2/25/21, 3/24/21 and 11/26/21. Recent admit 7/24-26/22 for acute on chronic systolic HF, bacterial and crytogenic PNA, Covid (+ on 7/23), COPD exacerbation and CKD3.  Readmitted on 8/1 for acute on chronic respiratory failure with hypoxia and PNA. Subsequently decompensated - transferred to ICU, intubated and placed on pressors. Developed rapidly worsening refractory pressor dependent shock and multi-system organ failure. Transitioned to comfort care. Expired 8/5. Tx'd with meropenem, cefepime, methylprednisolone, and nystatin.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Left ventricular failure, Multiple organ dysfunction syndrome, Organising pneumonia, Pneumonia
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Moderna vaccine on 2/25/21, 3/24/21 and 11/26/21. Recent admit 7/24-26/22 for acute on chronic systolic HF, bacterial and crytogenic PNA, Covid (+ on 7/23), COPD exacerbation and CKD3.  Readmitted on 8/1 for acute on chronic respiratory failure with hypoxia and PNA. Subsequently decompensated - transferred to ICU, intubated and placed on pressors. Developed rapidly worsening refractory pressor dependent shock and multi-system organ failure. Transitioned to comfort care. Expired 8/5. Tx'd with meropenem, cefepime, methylprednisolone, and nystatin.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pneumonia bacterial, SARS-CoV-2 test positive, Shock
Clinical narrative: Moderna COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Rec'd Moderna vaccine on 2/25/21, 3/24/21 and 11/26/21. Recent admit 7/24-26/22 for acute on chronic systolic HF, bacterial and crytogenic PNA, Covid (+ on 7/23), COPD exacerbation and CKD3.  Readmitted on 8/1 for acute on chronic respiratory failure with hypoxia and PNA. Subsequently decompensated - transferred to ICU, intubated and placed on pressors. Developed rapidly worsening refractory pressor dependent shock and multi-system organ failure. Transitioned to comfort care. Expired 8/5. Tx'd with meropenem, cefepime, methylprednisolone, and nystatin.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Laboratory test, Noninfective encephalitis, Pyrexia
Clinical narrative: Patient has the 3 Moderna doses, the first two she has fever, headache but no to bad, after the third dose she started with a big headache , and never went out en February started going to doctor, by March 2022 she went to emergency room, this headache caused an inflammation of the brain,  up today 08/10/2022 she has two times a drain outside the brain, and she did not show any recuperation, now last Friday August 5,2022 the doctors decided to add the drain inside, Our concern as a family is no any test making can show why she has the swollen brain, All those headaches started with vaccination, we can not prove it, but patient was a healthy person, very active, and with not bad health record in the pass, she never went to doctor before March 2022 to complain for any healthy issue, as a family we like to know is was a consequence of Moderna vaccine, ALL HER MEDICAL TEST ARE GOOD, no one show anything that can conduce the medicine to find why her swollen brain Please can some can call me, I am her sister
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated (1doseJanssen vaccine   )
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Medical facility consulted with the regulatory authority and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Medical facility is working with the regulatory authority on a compliance improvement plan and has been reinstated vaccination privileges.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy site unspecified abnormal, Swelling
Clinical narrative: In June of 2022, I noticed some swelling on the right side of my neck. I went to my PCP to have it checked out. I was referred to a specialist who scheduled a biopsy. The results came back and they said it looked suspicious so they scheduled a surgery to have my thyroid on the right side removed on September 23rd, 2022.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case COVID-19 after fully vaccinated with 3 doses Pfizer.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: The second Moderna COVID-19 dose was given at 20 days after the first dose (first dose 7/20/22) and not at recommended interval of 28 days after first dose. Parent notified the same day and no side effects noted at that time.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Consulted with the Dept of Public Health and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Clinic is working on a compliance improvement plan and has been reinstated vaccination privileges.